Merging homogeneous catalysis with biocatalysis; papain as hydrogenation catalyst

Chemical Communications

Volumn , Issue 45, 2005, Pages 5656-5658

  Panella, Lavinia ^a   Broos, Jaap ^a   Jin, Jianfeng ^a   Fraaije, Marco W ^a   Janssen, Dick B ^a   Jeronimus Stratingh, Margot ^a   Feringa, Ben L ^a   Minnaard, Adriaan J ^a   De Vries, Johannes G ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b DSM RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC ACID DERIVATIVE; METHYL 2 ACETAMIDOACRYLATE; PAPAIN; UNCLASSIFIED DRUG;

ARTICLE; BIOCATALYST; CATALYSIS; CATALYST; COMPLEX FORMATION; HYDROGENATION;

EID: 28944451442     PISSN: 13597345     EISSN: None     Source Type: Journal    
DOI: 10.1039/b512138h     Document Type: Article

References (57)

1. (a) Handbook of Chiral Chemicals, ed. D. J. Ager, CRC, Boca Raton, 2005;
2. (b) Asymmetric Catalysis on Industrial Scale, ed. H.-U. Blaser and E. Schmidt, Wiley-VCH, Weinheim, 2004.
3. J. G. de Vries and A. H. M. de Vries, Eur. J. Org. Chem., 2003, 799-811.
4. C. Gennari and U. Piarulli, Chem. Rev., 2003, 103, 3071.
5. (a) C. Claver, E. Fernandez, A. Gillon, K. Heslop, D. J. Hyett, A. Martorell, A. G. Orpen and P. G. Pringle, Chem. Commun., 2000, 961;
6. (b) M. T. Reetz and G. Mehler, Angew. Chem., Int. Ed., 2000, 39, 3889;
7. (c) M. van den Berg, A. J. Minnaard, E. P. Schudde, J. Van Esch, A. H. M. de Vries, J. G. de Vries and B. L. Feringa, J. Am. Chem. Soc., 2000, 122, 11539.
8. (a) L. Lefort, J. A. F. Boogers, A. H. M. de Vries and J. G. de Vries, Org. Lett., 2004, 6, 1733;
9. (b) A. Duursma, J. G. Boiteau, L. Lefort, J. A. F. Boogers, A. H. M. de Vries, J. G. de Vries, A. J. Minnaard and B. L. Feringa, J. Org. Chem., 2004, 69, 8045.
10. For recent overviews see: (a) F. H. Arnold, Nature, 2001, 409, 253;
11. (b) K. A. Powell, S. W. Ramer, S. B. del Cardayré, W. P. C. Stemmer, M. B. Tobin, P. F. Longchamp and G. W. Huisman, Angew. Chem., Int. Ed., 2001, 40, 3948;
12. (c) S. Brakmann and K. Johnsson, Directed Molecular Evolution Of Proteins (or How to Improve Enzymes for Biocatalysis), Wiley-VCH, Weinheim, 2002;
13. (d) F. H. Arnold and G. Georgiou, Directed Enzyme Evolution: Screening and Selection Methods, in Methods and Molecular Biology, vol. 230, Humana, Totowa, 2003;
14. (e) N. E. Labrou, Biomol. Eng., 2005, 22, 1-3, thematic issue on directed enzyme evolution.
15. (a) For a review on high-throughput ee-assays see: M. T. Reetz, Angew. Chem., Int. Ed., 2001, 40, 284;
16. (b) For a review on biocatalyst screening see: D. Wahler and J-L. Reymond, Curr. Opin. Chem. Biol., 2001, 5, 152;
17. (c) For a review on enantioselective miniaturized detectors see: T. J. Edkins and D. R. Bobbitt, Anal. Chem., 2001, 73, 488A.
18. D. Qi, C. M. Tann, D. Haring and M. D. Distefano, Chem. Rev., 2001, 101, 3081.
19. M. E. Wilson and G. M. Whitesides, J. Am. Chem. Soc., 1978, 100, 306.
20. (a) M. Skander, N. Humbert, J. Collot, J. Gradinaru, G. Klein, A. Loosli, J. Sauser, A. Zocchi, F. Gilardoni and T. R. Ward, J. Am. Chem. Soc., 2004, 126, 14411;
21. (b) C. Letondor, N. Humbert and T. R. Ward, Proc. Natl. Acad Sci. U. S. A., 2005, 102, 4683.
22. For a similar approach using a chiral ligand see: C.-C. Lin, C.-W. Lin and A. S. C. Chan, Tetrahedron: Asymmetry, 1999, 10, 1887.
23. (a) S. Nimri and E. Keinan, J. Am. Chem. Soc., 1999, 121, 8978;
24. (b) M. Ohashi, T. Koshiyama, T. Ueno, M. Yanase, H. Fujii and Y. Watanabe, Angew. Chem., Int. Ed., 2003, 42, 1005;
25. R. Ricoux, E. Lukowska, F. Pezzotti and J. P. Mahy, Eur. J. Biochem., 2004, 271, 1277;
26. A. Mahammed and Z. Gross, J. Am. Chem. Soc., 2005, 127, 2883.
27. H. L. Levine and E. T. Kaiser, J. Am. Chem. Soc., 1978, 100, 7670.
28. (a) R. R. Davies and M. D. Distefano, J. Am. Chem. Soc., 1997, 119, 11643;
29. (b) K. M. Nicholas, P. Wentworth Jr., C. W. Hartwig, A. D. Wentworth, A. Shafton and K. D. Janda, Proc. Natl. Acad Sci. U. S. A., 2002, 99, 2648.
30. (a) M. T. Reetz, Tetrahedron, 2002, 58, 6595;
31. (b) M. T. Reetz, M. Rentzsch, A. Pletsch and M. Maywald, Chimia, 2002, 56, 721.
32. J. R. Carey, S. K. Ma, T. D. Pfister, D. K. Garner, H. K. Kim, J. A. Abramite, Z. Wang, Z. Guo and Y. Lu, J. Am. Chem. Soc., 2004, 126, 10812.
33. For reviews on monodentate phosphorus ligands see: (a) F. Lagasse and H. B. Kagan, Chem. Pharm. Bull., 2000, 48, 315;
34. (b) I. V. Komarov and A. Börner, Angew. Chem., Int. Ed., 2001, 40, 1197;
35. T. Jerphagnon, J.-L. Renaud and C. Bruneau, Tetrahedron: Asymmetry, 2004, 15, 2101.
36. We hoped that additional binding sites for Rh(I), if necessary, could be found between the residues in the enzyme pocket, as for example His-159 positioned opposite Cys-25.
37. H. H. Otto and T. Schirmeister, Chem. Rev., 1997, 97, 133.
38. (a) T. Vernet, J. Chatellier, D. C. Tessier and D. Y. Thomas, Protein Eng., 1993, 6, 213;
39. (b) M. K. Ramjee, J. R. Petithory, J. McElver, S. C. Weber and J. F. Kirsch, Protein Eng., 1996, 9, 1055.
40. (a) J. Drenth, J. N. Jansonius, R. Koekoek, H. M. Swen and B. G. Wolthers, Nature, 1968, 218, 929;
41. (b) I. G. Kamphuis, K. H. Kalk, M. B. A. Swarte and J. Drenth, J. Mol. Biol., 1984, 179, 233.
42. E. Weber, H-J. Kohler, K. Panneerselvam and K. K. Chacko, J. Chem. Soc., Perkin Trans. 2, 1990, 1599.
43. F. R. Hewgill and F. Legge, J. Chem. Soc., Perkin Trans. 2, 1983, 653.
44. L. C. King and G. K. Ostrum, J. Org. Chem., 1964, 29, 3459.
45. G. J. H. Buisman, P. C. J. Kamer and P. W. N. M. van Leeuwen, Tetrahedron: Asymmetry, 1993, 4, 1625.
46. A. van Rooy, A. Orij, P. C. J. Kamer and P. W. N. M. van Leeuwen, J. Chem. Soc., Chem. Commun., 1991, 1096.
47. U. Christmann and R. Vilar, Angew. Chem., Int. Ed., 2005, 44, 366.
48. For a review on decomposition pathways in catalysis see: P. W. N. M. van Leeuwen, Appl. Catal., A, 2001, 212, 61.
49. 2O/acetone (δ 137.6).
50. A. Albeck and S. Kliper, Biochem. J., 1997, 322, 879.
51. In the spectrum a peak of residual oxidized papain (as its sulfinic acid) is also visible, together with a peak corresponding to the solely attached 3-hydroxy-phenacyl group resulting from the hydrolysis of the phosphite ligand. The presence of this peak seemed to be partially caused by the presence of formic acid necessary for the ESI-MS analysis.
52. 4 were used in the complexation step.
53. See: F. Pruchnik and L. Trynda, J. Inorg. Biochem., 1995, 58, 69.
54. An additional peak appears in the ESI-MS, that could be attributed to an adduct between papain in its reduced state and one unit of Rh(I)(COD).
55. 2 pressure was also obtained when the substrate to catalyst ratio was increased to 800 : 1.
56. The active site of papain is placed in a hydrophobic pocket with a cleft of about 15 Å and a groove of about 25 Å.
57. See: M. E. McGrath, Annu. Rev. Biophys. Biomol. Struct., 1999, 28, 181.